Aster Capital Management’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.61K Sell
328
-848
-72% -$17K ﹤0.01% 856
2026
Q2
$26.1K Buy
+1,176
New +$24.5K 0.01% 583
2026
Q1
– Sell
-95
Closed -$1.47K – 865
2025
Q4
$1.47K Buy
+95
New +$1.11K ﹤0.01% 986

Other funds holding JBIO

Aster Capital Management's JBIO Position: Q3 2026 in Review

Aster Capital Management reduced its Jade Biosciences (JBIO) stake by 72% in Q3 2026, selling an estimated $17K and leaving 328 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #856.

Aster Capital Management first reported a position in JBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $26.1K in Q2 2026. 162 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • Aster Capital Management held 328 shares of Jade Biosciences worth $4.61K as of Q3 2026.
  • Aster Capital Management sold 848 Jade Biosciences shares in Q3 2026, an estimated $17K.
  • Jade Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #856 holding.
  • Aster Capital Management first reported a position in Jade Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Aster Capital Management's Jade Biosciences position peaked at $26.1K in Q2 2026.
  • 162 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.